LABS score – a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study

No widely used prognostic tool exists to demonstrate the benefit of oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX4) in patients with advanced hepatocellular carcinoma (HCC). We aimed to establish a progno...

Source: BMC Cancer - March 1, 2024 Category: Cancer & Oncology Authors: Jirapat Wonglhow, Patrapim Sunpaweravong, Chirawadee Sathitruangsak and Arunee Dechaphunkul Tags: Research Source Type: research